The vOTU domain of highly-pathogenic porcine reproductive and respiratory syndrome virus displays a differential substrate preference  by Deaton, Michelle K. et al.
The vOTU domain of highly-pathogenic porcine reproductive and
respiratory syndrome virus displays a differential substrate preference
Michelle K. Deaton a, Allyn Spear b, Kay S. Faaberg b, Scott D. Pegan c,n
a Department of Chemistry and Biochemistry, University of Denver, Denver, CO 80208, USA
b Virus and Prion Research Unit, USDA-ARS-National Animal Disease Center, Ames, IA 50010, USA
c Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA 30602, USA
a r t i c l e i n f o
Article history:
Received 15 January 2014
Returned to author for revisions
6 February 2014
Accepted 24 February 2014
Available online 15 March 2014
Keywords:
vOTU
PLP2
PRRSV
nsp2
Ubiquitin
ISG15
a b s t r a c t
Arterivirus genus member Porcine reproductive and respiratory syndrome virus (PRRSV) causes an
economically devastating disease, recently exacerbated by the emergence of highly pathogenic strains
(HP-PRRSV). Within the nonstructural protein 2 of PRRSV is a deubiquitinating enzyme domain
belonging to the viral ovarian tumor (vOTU) protease superfamily. vOTUs, which can greatly vary in
their preference for their host ubiquitin (Ub) and Ub-like substrates such as interferon stimulated gene
15 (ISG15), have been implicated as a potential virulence factor. Since various strains of PRRSV have large
variations in virulence, the speciﬁcity of vOTUs from two PRRSV strains of varying virulence were
determined. While both vOTUs showed de-ubiquitinating activity and markedly low deISGylating
activity, HP-PRRSV demonstrated a strong preference for lysine 63-linked poly-Ubiquitin, tied to innate
immune response regulation. This represents the ﬁrst report of biochemical activity unique to HP-PRRSV
that has implications for a potential increase in immunosuppression and virulence.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV)
is a rapidly evolving virus which emerged as a serious pathogen of
swine in the late 1980s, and has since become one of the most
signiﬁcant concerns to the global pork industry. These concerns
have only been exacerbated by the emergence in 2006/2007 of
highly pathogenic PRRSV (HP-PRRSV) in China and Southeast Asia
(Guo et al., 2013a; Li et al., 2007; Wu et al., 2009). Although
initially characterized by a unique discontinuous 30 amino acid
deletion in nonstructural protein 2 (nsp2), it was later shown that
this deletion was not related to the increased virulence of these
isolates (Zhou et al., 2009). More contemporary PRRSV isolates
have been observed in SE Asia that show signiﬁcant continuing
evolution from the original 2006 isolates, but still retain the highly
pathogenic phenotype (Guo et al., 2013b; Yu et al., 2012). These
observations underscore the need to mechanistically understand
what is responsible for the increased virulence of HP-PRRSV,
which is further complicated by the complex and poorly under-
stood virulence determinants of the broad and genetically diverse
PRRSV strains.
PRRSV is a positive-sense, single-stranded RNA virus in the
genus Arterivirus of the family Arteriviridae. Phylogenetic analysis
of PRRSV reveals two genetically distinct genotypes: Type 1/
European PRRSV (type strain Lelystad) and Type 2/North American
PRRSV (type strain VR-2332), with the HP-PRRSV isolates belong-
ing to a distinct subgroup of Type 2. It is important to note,
however, that due to a high rate of mutation and recombination, it
is likely that actual genetic diversity of PRRSV continuously surges
ahead of our ability to discover and characterize it (Shi et al., 2010).
Upon infection with PRRSV, viremia is typically established in
6–12 h and virus shedding has been observed for up to 157 days
(Wills et al., 1997). It is likely that the prolonged time to virus
clearance is directly related to the immunosuppressive effects of
PRRSV infection. Not only does the infection of antigen presenting
cells (macrophages and dendritic cells) directly impair immune
activation, but the production of high levels of non-neutralizing
antibody to decoy epitopes and stimulation of immunosuppressive
cytokines may also contribute to pathogenesis (Charerntantanakul
et al., 2006; Sang et al., 2011; Yoo et al., 2010). In addition to a
subversion of the adaptive immune response, some strains of
PRRSV initiate a comprehensive campaign against the innate
immune response including a complex dysregulation of the
type I interferon/IRF/NF-κB pathway in cultured cells (Beura
et al., 2010; Fang et al., 2012; Song et al., 2010; Sun et al.,2010,
2012a; van Kasteren et al., 2013). While the mechanisms of certain
aspects of this dysregulation have been determined, the role of
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PRSRV nsp2 remains convoluted. Due to the high degree of
variability in nsp2, it remains likely that functional differences
exist in nsp2 between various PRRSV isolates that might have
consequences on strain virulence.
PRRSV nsp2 is a large, highly variable protein encoded in the
ORF1a region of the genome as part of a larger polyprotein
precursor (Han et al., 2006; Snijder et al., 1995; van Hemert and
Snijder, 2008). Nsp2 is liberated from this precursor via cleavage of
the nsp1β:nsp2 junction by the nsp1β protease and cleavage of the
nsp2:nsp3 junction by the intrinsic protease activity of nsp2 (den
Boon et al., 1995; Han et al., 2009a; Snijder et al., 1995; van Hemert
and Snijder, 2008). This protease activity resides within an amino-
terminal region of nsp2 containing a papain-like cysteine protease
domain (PLP2) that cleaves at a conserved GG dipeptide between
nsp2 and nsp3 (Han et al., 2009b; Mielech et al., in press; Ziebuhr
et al., 2000). It has also been shown bioinformatically that this
PLP2 domain is part of a larger family of mammalian proteins
known as the ovarian tumor domain (OTU) proteases (Frias-Staheli
et al., 2007). This subgroup of viral OTU domains (vOTU) have been
biochemically shown to act as deubiquitinases (DUB) of varying
speciﬁcities and activities, capable of interfering with innate
immune responses via dysregulation of ubiquitin (Ub) or ISG15
related protein signaling (Akutsu et al., 2011; Capodagli et al.,
2013; Capodagli et al., 2011; Frias-Staheli et al., 2007).
The Ub polychain formation, also known as polyubiquitination,
forms via isopeptide bond between a Ub C-terminus with either
the N-terminus, or one of seven other lysines, of another Ub
molecule. Both mono- and polyubiquitination of host proteins act
as key regulatory steps in multiple distinct cell signaling pathways
(Komander et al., 2009; Kulathu and Komander, 2012). One
relevant example of this is the use of K63-linked poly-Ub in the
activation of retinoic acid-inducible gene I/mitochondrial antiviral
signaling protein (RIG-I/MAVS) (Zeng et al., 2010), linear poly-Ub-
dependent activation of inhibitors (IκB kinases) of nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB) (Tokunaga
et al., 2009), and K48-linked poly-Ub to trigger degradation of IκB
and activation of NF-κB signaling (Alkalay et al., 1995; Chen et al.,
1995). Alternative forms of ubiquitination (K6, K11, K27 and K33)
have been implicated in other cellular functions, including lyso-
some/vesicle trafﬁcking, DNA damage response, inhibition of
protein degradation, mitochondrial damage/autophagy, endoplas-
mic reticulum (ER) associated protein degradation, T-cell activa-
tion, and tumor necrosis factor-alpha (TNFα) signaling (Kulathu
and Komander, 2012). Further, there exist multiple Ub-like pro-
teins, such as interferon (IFN) stimulated gene 15 (ISG15), for
which there are diverse functions and regulatory pathways includ-
ing anti-viral host defense (Zhao et al., 2013). It is clear from this
diverse and interwoven set of processes that it is insufﬁcient to
simply deﬁne a protease as a vOTU or DUB and subsequently
ascertain the global picture of downstream cellular effects.
Herein, we describe detailed biochemical characterization of
the vOTU activity of the PLP2 domain from a HP-PRRSV strain
(JXwn06), and contrast that activity to that from the PLP2 domain
of the avirulent modiﬁed live virus vaccine strain Ingelvac PRRSs
(MLV). To do this, we utilized puriﬁed vOTU domains in an in vitro
activity assay with chemically deﬁned, puriﬁed substrates. This
system provides signiﬁcant advantages to in cellulo and in vivo
activity assays, including the ability to directly query substrate
preference and observe simpliﬁed reaction kinetics. Further, these
assays avoid complications due to off-target effects or effects on
complex cellular pathways which can make data interpretation
problematic. Using this approach, we demonstrate that both the
MLV and JXwn06 vOTU/PLP2 domains showed DUB activity on
K48-Ub and K63-Ub substrates, respectively. Interestingly, the
PLP2 domain from HP-PRRSV strain JXwn06 displayed signiﬁcantly
greater activity against K63-Ub substrates than the PLP2 domain of
MLV. This represents the ﬁrst report of a biochemical activity
unique to HP-PRRSV that has potential implications for increased
immunosuppression and may contribute to the increased viru-
lence exhibited by this Asian HP-PRRSV strain.
Results
Sequence comparison of PRRSV strain JXwn06 and MLV vOTU
domains
The vOTU domains of very few strains of PRRSV have been
directly examined for suppression of innate immunity in cell
culture. Two such studies utilized SD01-08 (a Type 1 isolate)
(Sun et al., 2010) or VR-2332 (van Kasteren et al., 2012), which
both cause only mild disease in vivo, and neither of which included
an assessment of enzyme kinetics. Another study examined the
ability of HP-PRRSV strain 07HBEZ vOTU to suppress IFN-β induc-
tion in vitro (Li et al., 2010). To more precisely examine and
compare vOTU domain enzymatic activity and speciﬁcity for
PRRSV strains of differing pathogenicity, the vaccine derivative
Ingelvac PRRSsMLV and HP-PRRSV strain JXwn06 were chosen for
analysis. A vOTU domain alignment of these two PRRSV strains
compared to a related arterivirus (equine arteritis virus; EAV) and
CCHFV was produced, using the catalytic and zinc-binding resi-
dues as alignment signature amino acids (Fig. 1). The two PRRSV
strains display 83.7% identity/84.2% similarity within the desig-
nated vOTU region, while this domain displays 21% identity
between both PRRSV strains and EAV, and only 10% identity
between PRRSV and CCHFV.
Fig. 1. Sequence alignment of vOTUs. Sequence similarity is indicated as non-conserved (white background, black text), similar (yellow background, black text), conserved
(green background, white text), or all matching (dark green background, orange text). Catalytic residues are boxed in red, and zinc-binding residues are boxed in purple.
PRRSV sequence numbering is based on the residue number within nsp2.
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Characterization of strain speciﬁcity
In order to investigate potential functional differences between
vOTU domains from different PRRSV strains, we obtained bio-
chemical data on the activity and speciﬁcity of PRRSV vOTU
domains from strains JXwn06 and MLV. Initially, enzymatic activ-
ity was assessed utilizing Ub and ISG15 substrates, as well as a
peptide substrate comprised of ﬁve C-terminal amino acids
common to Ub and ISG15, RLRGG (Fig. 2). By monitoring the
release of the aminomethylcoumarin ﬂuorophore from the
C-terminus of these substrates, rate and substrate preference data
was obtained. The vOTU domains originating from JXwn06 and
MLV possess a noteworthy ability to cleave human Ub-AMC (hUb-
AMC) conjugates, at 3.6770.04 and 2.3070.04 min1, respec-
tively. However, when these vOTUs were assessed for activity
against human ISG15-AMC (hISG15-AMC), the vOTUs of JXwn06
and MLV exhibited activity 2500 and 320 times less than their
activities toward Ub-AMC, respectively. Interestingly, when
assessed using the peptide substrate ZRLRGG-AMC, which is
comprised of the last ﬁve conserved amino acids between Ub
and ISG15, a large deviation in activity was observed between the
vOTUs from MLV and JXwn06. Speciﬁcally, the activity of the MLV
vOTU was 0.4070.04 min1, whereas JXwn06 vOTU was only
2.0570.01102 min1. This result, as well as the dramatic
difference between cleavage of Ub-AMC and hISG15-AMC, suggest
a more complex interaction with the protein substrate beyond
simple recognition of peptide sequence.
Fig. 2. Kinetic data for ﬂuorescence based assay. JXwn06 vOTU data is shown in
gray and MLV vOTU data is shown in white. ISG15-AMC data is shown in the insert
for clarity. Turnover number of substrate is measured as increase in ﬂuorescence as
AMC is cleaved off of the substrate molecule.
Fig. 3. Cleavage of di- and tri- Ub. (a) Cleavage of various di-Ub linkages by JXwn06 and MLV vOTUs. (b) Kinetic data for FRET based Di-Ub assay. JXwn06 vOTU data is shown
in gray and MLV vOTU data is shown in white. (c) Cleavage of tri-Ub by JXwn06 vOTU and MLV vOTU.
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Di-ubiquitin speciﬁcity divergence
In some cases, vOTU domains have been shown to have higher
turnover rates for poly-Ub than for Ub-AMC due to an increase in
the number of favorable contacts to which the enzyme can bind
the substrate (Capodagli et al., 2013). Although the activity for
mono-Ub was found to be relatively similar between JXwn06 and
MLV vOTUs, differences in rates of cleavage for di-Ub may exist
between strains. To more precisely differentiate the di-Ub speciﬁ-
cities of the JXwn06 and MLV vOTU domains, a panel of varying
di-Ub substrates (composed of K6, 11, 27, 29, 33, 48, 63 and linear di-
Ub linkages; Fig. 3a) was screened for activity. Both vOTU domains
had an overall trend of highest activity towards K63 linked di-Ub,
followed by (in descending order) K11, K29, K6, K27, and K48-linkage,
with no detectable activity toward linear linked di-Ub. Interestingly,
while the observed activity was similar for most di-Ub linkages,
JXwn06 vOTU was markedly more active toward K63 di-Ub, cleaving
nearly all of the substrate within 10 min, compared to the MLV vOTU,
for which a signiﬁcant proportion of uncleaved K63 substrate
remained after 60 min. In order to quantify the difference in activity
towards di-Ub substrates, cleavage of K11, K48, and K63 di-Ub FRET
substrates was assessed. These results aligned with the di-Ub gel
shift assays, with both vOTU domains displaying low activity towards
K48 linked di-Ub, and disparate activities utilizing K63 linked di-Ub.
The activity of the JXwn06 vOTU towards K63 linked di-Ub was
determined to be approximately 40-fold higher than that of MLV
vOTU (Fig. 3b).
To assess potential differences in vOTU domain activity on
substrates similar to poly-Ub, activity assays were performed using
K48 and K63 linked tri-Ub (Fig. 3c). In stark contrast to the K48
linked di-Ub substrate, both vOTU domains of MLV and JXwn06
rapidly cleaved the majority of K48 tri-Ub into di- and mono-Ub
within 5 min. However, consistent with the previous results, the
resulting K48 linked di-Ub appeared refractory to subsequent
vOTU cleavage. As in the di-Ub cleavage assay, the K63 linked
tri-Ub substrate was rapidly and completely cleaved to mono-Ub
by the JXwn06 vOTU domain within 10 min. Unlike the surge in
activity observed using K48 linked tri-Ub for the MLV vOTU
domain, its cleavage of K63 linked tri-Ub proceeded at the same
modest rate observed for K63 di-Ub.
proISG15 activity
While Ub is highly conserved among species, ISG15 is more
divergent, with human and porcine ISG15 sharing 67% sequence
homology (Fig. 4a). Nairovirus vOTUs such as the CCHFV vOTU
have previously been demonstrated to possess species speciﬁcity
for ISG15 (Capodagli et al., 2013). To determine if the low hISG15-
AMC activity observed for JXwn06 and MLV vOTU domains was
also related to species speciﬁcity, cleavage of the pro-form of
human (hproISG15) and porcine (pproISG15) were examined,
using the CCHFV vOTU as a control. First, cleavage of hproISG15
was examined. At the low enzyme concentration of 20 nM, CCHFV
Fig. 4. (a) Sequence alignment of C-terminal end of human (top) and porcine (bottom) ISG15. (b) ProISG15 gel shift assay. Cleavage of human (h) proISG15 by CCHFV,
JXwn06, or MLV vOTU is shown over a one-hour time course and visualized by coomasie blue staining. (c) Cleavage of porcine (p) proISG15 by varying concentrations of
CCHFV, JXwn06 and MLV vOTUs are shown over a one hour time course as well as a 24 h time point. Cleavage products were visualized by anti-FLAGs western blot of
tagged-pproISG15.
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vOTU cleaved the hproISG15 at a rate that was readily observed in
the one-hour time trial. Since the PRRSV vOTUs exhibited much
lower turnover numbers for hISG15-AMC, the highest allowable
concentrations of MLV and JXwn06 were utilized. However, even
at the increased concentrations for MLV and JXwn06 vOTUs, no
cleavage of the hproISG15 was observed for either in the one-hour
time span (Fig. 4b). When examining cleavage of pproISG15, while
CCHFV vOTU was seen to cleave the pproISG15 at a signiﬁcantly
reduced rate to that of hproISG15, no cleavage of pproISG15 by
JXwn06 and MLV vOTU domains was detected within a one-hour
time course. It was only after an extended 24-hour incubation that
a trace of cleaved product was observed (Fig. 4b and c).
Discussion
The identiﬁcation of a vOTU domain in nsp2 of the arterivirus
PRRSV sets it among a number of viruses containing vOTUs, including
nairoviruses, tymoviruses, a tenuivirus, and other nidoviruses.
Recently, vOTUs from nairovirus representatives CCHFV, Dugbe virus
and Erve virus (ERVEV), as well as the tymovirus prototypical member
turnip yellow mosaic virus (TYMV) were probed extensively, and
illustrated vOTUs from different species can vary greatly in their
preference for substrate (Capodagli et al., 2013). The vOTUs from
JXwn06 and MLV follow this trend. Relative to previously character-
ized vOTU domains of viruses, JXwn06 and MLV vOTU domains
displayed moderate deubiquitinating activity. The vOTUs previously
probed have deubiquitinating activity which ranges from approxi-
mately 0.03 to 27 min1 (Capodagli et al., 2013). The PRRSV vOTUs fall
into the lower end of this range, with deubiquitinating activity closest
in value to that of ERVEV vOTU, which is considered a poor
deubiquitinating enzyme relative to other nairoviruses (Capodagli
et al., 2013). However, relative to nairovirus counterparts, such as
vOTUs from CCHFV and ERVEV, that clearly possess deISGylating
activity, PRRSV vOTUs deISGylating activity is extremely low. Com-
paratively, other vOTUs have activity ranging from ERVEV vOTU at the
high end, at 15 min1, to TYMV vOTU at the low end with activity of
only 0.005 min1. The PRRSV vOTUs hISG15 activities are near the
lower end of these reported vOTU activities, with similar values to the
TYMV vOTU, whose plant host lacks an ISG15 homolog. Upon
comparing the proteolytic activity of the PRRSV vOTUs toward the
last ﬁve amino acids common to both Ub and ISG15 as measured by
cleavage of ZRLRGG-AMC, a divergence in their comparative activities
was found. The activity of the MLV vOTU is 20 times greater than that
of the JXwn06 vOTU and 30% greater than the highest activity
observed in the recent survey of representative vOTU domains
reported by (Capodagli et al., 2013).
Further comparison and analysis of the vOTU domain from the
highly pathogenic JXwn06 strain of PRRSV with the vOTU domain
of the less pathogenic North American MLV strain revealed an
intriguing result. The less virulent MLV vOTU maintained a better
proteolytic activity, as measured by fold change of relative clea-
vage of ZRLRGG-AMC, and the two vOTUs had similar moderate
Ub-AMC activity. However, upon examining the activity of the two
strain's vOTUs towards poly-linked Ub, rather than the mono-Ub-
AMC, a large divergence in their activities was uncovered. The
JXwn06 vOTU exhibited K63 linked Ub activity over 40 times
greater than that of MLV, exemplifying how vOTUs with similar
activity against mono-Ub may have divergent activity towards
different di-Ub linkages. Suppression of K63 linked poly-Ub early
in infection by JXwn06 may contribute to the increased disease
severity in highly pathogenic PRRSV infection.
During initial examination of vOTU domains, such as that from
CCHFV, it was theorized that all vOTUs might possess dual
deubiquitinating and deISGylating activity. However, further
work demonstrated that some vOTUs likely serve primarily as
deubiquitinases, while others may have a stronger preference for
ISGylated substrates (Capodagli et al., 2013). For PRRSV vOTU
domains from Jxwn06 and MLV, both were found to not only have
very low activity against hISG15-AMC, but were unable to appre-
ciably cleave either pproISG15 or hproISG15. The latter experiment
eliminates a species-speciﬁcity effect, as seen in CCHFV vOTU, as
the primary driver for the absence of activity (Fig. 4b and c). As a
result, the lack of deISGylating activity suggests that PRRSV core
domain may be more suited as a deubiqutinase than a deISGylase.
The lack of deISGylating activity is surprising given that PRRSV
nsp2 has been previously suggested to play a direct role in
reducing the amount of ISGylation in cells (Sun et al., 2012b). This
may indicate additional protein requirements for cleavage of ISG15
by PRRSV vOTUs. These additional requirements may come in the
form of accessory proteins, or in a requirement for a larger domain
within the nsp2 protein, as it has previously been demonstrated
that larger proteolytically active domains of nsp2 were required
for trans vs. cis cleavage speciﬁcities (Han et al., 2009a). Alterna-
tively, the observed cleavage of ISG15 modiﬁed proteins in cell
culture may be due to an upstream effect of nsp2, rather than a
direct effect of vOTU domain activity. Also, the extended time
course inherent in cellular testing, coupled with the observed
trace activity of PRRSV vOTUs for ISGylated substrates, may have
permitted the gradual buildup of deISGylated substrates thereby
exaggerating the magnitude of PRRSV vOTU's deISGylating activ-
ity. This is of particular importance, given the kinetics of the
antiviral response, particularly in the early stages of viral infection.
PRRSV virulence and attenuation have been studied exten-
sively, with most studies implicating multiple regions of the virus
in contributing to virulence, consistent with the observation that
individual PRRSV vaccines appear to have become attenuated by
different mechanisms (An et al., 2011; Brockmeier et al., 2012;
Ellingson et al., 2010; Han et al., 2013; Kim et al., 2010; Kwon et al.,
2008; Ni et al., 2013; Nielsen et al., 2001; Shi et al., 2013; Song
et al., 2010; Storgaard et al., 1999; Wang et al., 2008; Yuan et al.,
2001). Narrowing the focus to the PLP2/vOTU region of nsp2,
previous reports have generally demonstrated deubiquitinating
activity of certain strains, leading to subsequent suppression of
innate immune responses in infected cells (Frias-Staheli et al.,
2007; Li et al., 2010; Sun et al., 2010; van Kasteren et al., 2012),
suggesting a mechanistic role in PRRSV virulence. In this report,
we have shown that the core vOTU domain (215 residues), which
varies only 17% (amino acid identity) between different strains of
PRRSV, was responsible for marked differences in K63-linked
deubiquitination, reinforcing the role of the PLP2/vOTU domain
in virulence variation between PRRSV strains. It is important to
note that this core domain must function primarily as a viral
protease, placing signiﬁcant constraints on evolution of secondary
functions. This also underscores the complexities of PRRSV viru-
lence, since MLV and its parental ﬁeld isolate (VR-2332) share the
identical vOTU domain sequence while exhibiting differential
pathogenicity in swine. Therefore it is crucial to recognize that
while differential vOTU activity may contribute to virulence, it
remains one of a constellation of potential virulence factors.
Mechanistically, several critical innate immune sensors and cel-
lular anti-viral pathways utilize K63 ubiquitination as an essential
activation step, such as RIG-I/MAVS, MDA5, and MITA/STING
(Jiang et al., 2012; Oshiumi et al., 2013). Antagonism of these path-
ways by a vOTU domain with preference for K63-polyubiquitin could
lead to a decrease in type I interferon production and NF-κB
signaling, thereby abrogating or signiﬁcantly delaying establishment
of the anti-viral state. If K63 preference and increased deubiquitina-
tion activity of the JXwn06 vOTU domain is a shared characteristic
of all highly-pathogenic PRRSV isolates, then it is possible that
this unique activity contributes to the increased virulence of these
strains.
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Methods
Construction of OTU domains and porcine proISG15
Ingelvac PRRSs nsp2 nucleotides 1342–1986, coding for nsp2
aa 1-215, were inserted downstream of a 6 histidine tag, codon
optimized for expression in E. coli, and used to synthesize the viral
OTU polypeptide (MLV vOTU) (GenScript, Piscataway, NJ). A
JXwn06 vOTU polypeptide representing nsp2 aa 1-215 was pro-
duced in a like manner. The coding sequence for porcine proISG15
(NM_0011286469) was codon optimized for expression in E. coli,
and internal restriction endonuclease recognition sequences were
altered by silent mutagenesis for cloning purposes (Huang et al.,
2009). This optimized gene was synthesized with an amino
terminal 3 FLAG-Tag and 10 His-Tag, as well as NcoI and
BamHI sites for cloning purposes at the 50 and 30 ends, respectively
(GenScript). This synthetic gene was subcloned into pUC57 and
subsequently moved to pET26b (EMD Millipore) for bacterial
expression and puriﬁcation.
Protein puriﬁcation
Porcine proISG15 (pproISG15) was puriﬁed from E. coli BL21
(DE3) cells harboring the gene for pproISG15 grown at 37 1C in 6 L
of LB broth containing 100 mg/mL of ampicillin until the optical
density at 600 nm reached 0.6. Expression of pproISG15 was
induced by the addition of IPTG to a ﬁnal concentration of
0.5 mM at 20 1C overnight. The cells were resuspended in cold
Buffer A (50 mM Tris [pH 7.5], 1 mM EDTA, and 20% (w/v) sucrose),
and then centrifuged at 6700 g for 30 min. The cells were then
resuspended in 5 mM MgCl2. The suspension was centrifuged at
6700 g for 30 min, and the protein was puriﬁed from the super-
natant via Ni-NTA afﬁnity, followed by size-exclusion chromato-
graphy on a Superdex75 using Buffer B (200 mM NaCl, 20 mM
HEPES [pH 7.5], 2 mM DTT). The protein was further puriﬁed by
cation exchange using a 10/100 MonoS column. The protein was
eluted using a gradient from Buffer C (100 mM NaCl, 50 mM
ammonium acetate [pH 4.5]) to Buffer D (1000 mM NaCl, 50 mM
ammonium acetate [pH 4.5]). The vOTU from Crimean Congo
hemorrhagic fever (CCHFV vOTU) was puriﬁed as described pre-
viously (Capodagli et al., 2011).
Fluorescent vOTU deubiquitination and deISGylation assays
All assays were performed in duplicate in Buffer E (100 mM NaCl,
50 mM HEPES [pH 7.5], 0.01 mg/mL bovine serum albumin (BSA),
5 mM DTT) using a Corning Costar half-volume black 96-well plate
with a reaction volume of 50 μL. The rates of the reactions were
observed using an Inﬁnite M1000 series plate reader (Tecan, Inc.).
Speciﬁcally, the increase in ﬂuorescence (excitation λ, 360 nm; emis-
sion, 460 nm) of 7-amino-4-methylcourmarin (AMC) upon cleavage
from hUb-AMC, hISG15-AMC, (Boston Biochem, MA) and ZRLRGG-
AMC (Bachem) substrates was monitored for JXwn06 and MLV vOTU
(GenScript). To calculate turnover rates for 1 μM hISG15-AMC, 1 μM
hUb-AMC, and 50 μM ZRLRGG-AMC, 1 μM, 4 nM, and 4 μM of enzyme
were used against hISG15-AMC, hUb-AMC, and ZRLRGG-AMC,
respectively.
The turnover rates for poly-Ub ﬂuorescence resonance energy
transfer (FRET) linkage substrates K11, K48, and K63 (Boston
Biochem, MA) at 1 μM were determined by monitoring the
increase in ﬂuorescence (excitation λ, 544 nm; emission, 572 nm)
resulting by the separation of a FRET TAMRA/QXL pair. Cleavage of
three commercially available FRET TAMRA/QXL pair conﬁgurations
per K48 and K63 poly-Ub linkage FRET substrates were assessed.
Each di-Ub FRET substrate at 1 μM was evaluated against an
enzyme concentration of 500 nM.
Gel shift assays
Poly-Ub linked by the different isopeptide bonds (K6, K11, K29,
K33, K48, and K63), as well as the N-terminal peptide bond
(linear), were purchased from Boston Biochem, MA. K27 linked
di-Ub was purchased from Ubiquigent. Dimeric-Ub substrates
(10 μM) were incubated with 500 nM JXwn06 or MLV vOTU in
reaction Buffer F (100 mM NaCl, 50 mM HEPES [pH 7.5], and 2 mM
DTT) at 37 1C. Reactions were stopped at various times over 1 h by
mixing 9 μL of each reaction with 2 SDS-Tricine sample buffer
and heating at 95 1C for 5 min. Results were visualized on 10–20%
Mini-PROTEANs Tris–Tricine Precast Gels (Bio-Rad, CA). For vOTU
cleavage of trimeric K48 and K63 linkages, 20 μM of tri-Ub
substrates were tested and analyzed in the same manner as di-Ub.
10 μM hproISG15, (Boston Biochem, MA) was incubated with
20 nM CCHFV vOTU, 14 μM MLV, or 20 μM JXwn06 vOTU. 10 μM
pproISG15 was incubated with 20 nM CCHFV vOTUs. ProISG15 gel
shift assays were tested and analyzed in the same manner as di-
Ub. The concentrations of MLV and JXwn06 used were the
maximum allowable concentration possible for this assay.
Assay for vOTU cleavage of porcine proISG15 by anti-FLAGs western
blotting
The pproISG15 cleavage assays were assembled as described above
in reaction buffer F, containing 10 μM pproISG15, and either 100 nM
CCHFV vOTU or 1000 nM PRRSV vOTU domain. Reactions were
incubated at 37 1C, and aliquots were removed at time 0, 1, 2, 5, 10,
30, and 60min, as well as at 24 h. Reaction progress was halted by
addition of the removed aliquots to an equal volume of SDS-PAGE
loading buffer and storage at 20 1C until electrophoresis.
Timepoint samples for pproISG15 cleavage assays were sepa-
rated by 10% Tris–Tricine SDS–PAGE, and resolved proteins were
transferred to a PVDF membrane using the iBlot transfer apparatus
(Life Technologies). The membrane was blocked with 3% milk in
PBS and immunoblotted with a 1:3000 dilution of mouse α-FLAGs
monoclonal antibody (Sigma-Aldrich; F1804). Proteins were
detected using a 1:15000 dilution of peroxidase conjugated goat
α-mouse IgG antibody (Zymax, Life Technologies) and the ECL Plus
substrate (Pierce). Immunoblots were visualized using blue light
ﬂuorescence in a G:BOX imager (Syngene).
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